GlassScriptPhysician profile
Jesse C Ethridge
NPI 1043263841
$4,653.53
in general payments reported to CMS, 2019-2025
40 companies · $558 in 2025
The $558 reported for 2025 was more than what 83% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $572 · 2021: $1,089 · 2022: $361 · 2023: $1,221 · 2024: $255 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,273 · Travel and Lodging: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.17 |
| Travel and Lodging | $761.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $981.87 | 2019-2025 | |
| Intuitive Surgical, INC. | $637.49 | 2019-2023 | Da Vinci Surgical System |
| Applied Medical Resources Corporation | $525.98 | 2023 | Gelpoint V-Path |
| Pfizer INC. | $323.36 | 2019-2024 | |
| Coopersurgical, INC. | $271.24 | 2019-2021 | |
| Conmed Corporation | $193.56 | 2024-2025 | Airseal |
| Gynesonics, INC. | $141.05 | 2021 | |
| Hologic Sales and Service, LLC | $127.54 | 2023-2025 | Myosure Tissue Removal Device, Novasure |
| Aspira Women'S Health INC | $122.61 | 2021 | |
| Astellas Pharma US INC | $118.17 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $108.69 | 2023-2025 | Myfembree, Gemtesa |
| Shield Therapeutics INC | $87.84 | 2022-2024 | Accrufer |
| Exeltis, USA INC. | $81.49 | 2021-2023 | Slynd |
| Mayne Pharma Commercial LLC | $79.69 | 2023-2025 | |
| Minerva Surgical, INC | $74.44 | 2025 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Ethridge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.